secobarbital will reduce the extent or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Intently. Consider a rise in cannabidiol dosage (according to clinical reaction and tolerability) when coadministered with a powerful CYP3A4 inducer.Right after binding acetylcholine, the AChR responds by an ex